These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 23220502)
1. Effects of the glucose-lowering rate on cTnI and hs-CRP serum levels in type 2 diabetics. Wu W; Li Q; Xia J; Wang M; Sun Z; Miao J; Zheng Z Hum Immunol; 2013 Mar; 74(3):379-82. PubMed ID: 23220502 [TBL] [Abstract][Full Text] [Related]
2. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status. Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587 [TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile. Asegaonkar SB; Marathe A; Tekade ML; Cherekar L; Bavikar J; Bardapurkar J; Ajay R J Diabetes Complications; 2011; 25(6):368-70. PubMed ID: 22055258 [TBL] [Abstract][Full Text] [Related]
4. Influence of the glucose-lowering rate on left ventricular function in patients with type 2 diabetes and coronary heart disease. Wu W; Sun Z; Li Q; Wang M; Miao J; Zheng Z; Sun L; Huang J; Wang Y; Zhang H; Hu C J Diabetes Complications; 2012; 26(2):83-8. PubMed ID: 22475635 [TBL] [Abstract][Full Text] [Related]
5. Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery. Kouvelos GN; Milionis HJ; Arnaoutoglou EM; Chasiotis G; Gartzonika C; Papa NK; Tzimas P; Matsagkas MI Coron Artery Dis; 2011; 22(6):428-34. PubMed ID: 21730823 [TBL] [Abstract][Full Text] [Related]
6. Effects of five-year intensive multifactorial intervention on the serum amyloid A and macroangiopathy in patients with short-duration type 2 diabetes mellitus. Du JL; Liu JF; Men LL; Yao JJ; Sun LP; Sun GH; Song GR; Yang Y; Bai R; Xing Q; Li CC; Sun CK Chin Med J (Engl); 2009 Nov; 122(21):2560-6. PubMed ID: 19951570 [TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study. Onitilo AA; Engel JM; Stankowski RV; Liang H; Berg RL; Doi SA Breast Cancer Res Treat; 2012 Jul; 134(1):291-8. PubMed ID: 22476854 [TBL] [Abstract][Full Text] [Related]
8. [Plasma level of adiponectin in coronary heart disease patients combined with abnormal glucose metabolism]. Xia K; Guo L; Zhao Z; Md Sayed AS; Li F; Yang T Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):179-84. PubMed ID: 22561436 [TBL] [Abstract][Full Text] [Related]
9. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease? Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860 [TBL] [Abstract][Full Text] [Related]
10. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243 [TBL] [Abstract][Full Text] [Related]
11. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients. Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159 [TBL] [Abstract][Full Text] [Related]
12. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430 [TBL] [Abstract][Full Text] [Related]
13. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032 [TBL] [Abstract][Full Text] [Related]
14. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835 [TBL] [Abstract][Full Text] [Related]
15. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study. Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans. Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Goldberg RB; Fonseca VA; Truitt KE; Jones MR Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165 [TBL] [Abstract][Full Text] [Related]
18. Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients. Lecomte P; Foubert L; Coddens J; Dewulf B; Nobels F; Casselman F; Cammu G J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):937-42. PubMed ID: 21640613 [TBL] [Abstract][Full Text] [Related]
19. Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Al-Daghri N; Chetty R; McTernan PG; Al-Rubean K; Al-Attas O; Jones AF; Kumar S Cardiovasc Diabetol; 2005 Jul; 4():10. PubMed ID: 15998471 [TBL] [Abstract][Full Text] [Related]
20. Antioxidant status in coronary heart disease (CHD) patients with type 2 diabetes mellitus. Bansilal ; Ali N; Afzal N; Khan TS; Shahjahan S J Ayub Med Coll Abbottabad; 2007; 19(4):98-101. PubMed ID: 18693610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]